Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
40.2M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
3.7M
-
Shares change
-
+3.7M
-
Total reported value, excl. options
-
$108M
-
Value change
-
+$108M
-
Number of buys
-
31
-
Price
-
$29.32
Significant Holders of Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) as of Q2 2020
31 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.7M shares
of 40.2M outstanding shares and own 9.19% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.21M shares), Ikarian Capital, LLC (528K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (433K shares), BAKER BROS. ADVISORS LP (200K shares), BlackRock Inc. (92.4K shares), Eversept Partners, LP (46.3K shares), BOOTHBAY FUND MANAGEMENT, LLC (44K shares), RENAISSANCE TECHNOLOGIES LLC (30K shares), STATE STREET CORP (18.2K shares), and GEODE CAPITAL MANAGEMENT, LLC (17.4K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.